99m Tc-TRODAT-1) and 123 I-iodobenzamide ( 123 I-IBZM) are radiotracers for brain dopamine preand postsynaptic neuron imaging. The purpose of this study was to evaluate imaging parameters and crossed energy interference using simultaneous single photon emission computed tomography (SPECT) 99m Tc and 123 I data acquisition. A five-compartment brain striatal phantom was filled with 99m Tc and/or 123 I radioactive solutions with different striatal-to-background ratios, ranging from 3:1 to 9:1. SPECT data were acquired with energy window settings of 15% for the centered window at 140 keV for 99m Tc and a 10% asymmetric window at 159 keV for 123 I. The experiments were carried out using either individual ( 99m Tc or 123 I only) or both radionuclides. The striatal-to-background ratios and energy crossed interference between 99m Tc and 123 I were calculated. The phantom SPECT images demonstrated that the energy crossed interferences from 123 I to 99m Tc, and vice versa, were 22 ± 12.4% and 0.4 ± 1.0%, respectively. A net interference of 7.1 ± 4.0% for the counts in the 15% centered 99m Tc window can be expected from 123 I and a net interference of 1.6 ± 3.3% for the counts in the 10% asymmetric 123 I window was derived from 99m Tc. The correlation of striatal-to-background ratios between single isotope and simultaneous dual-isotope was excellent (R 2 = 0.99). The imaging parameters used in this simultaneous dualisotope SPECT imaging could be used in future clinical practice for imaging patients with movement disorders by using 99m Tc-TRODAT-1 and 123 I-IBZM. The striatal-to-background ratios were not affected by the crossed interference between 99m Tc and 123 I. Key Words: 123 I-IBZM, 99m Tc-TRODAT-1, brain striatal phantom, SPECT (Kaohsiung J Med Sci 2009;25:601-7)
P.F. Kao, S.P. Wey, and A.S. Yang Dual-isotope imaging is a valuable technique to concurrently investigate two different mechanisms with radiotracers in a specific organ to identify the nature of a lesion in an identical spatial registration. Parathyroid 201 Tl/ 99m Tc dual-isotope subtraction imaging has been widely used since the 1980s. In the 1990s, the dual-isotope cardiac single photon emission computed tomography (SPECT) technique was developed for the diagnosis of acute myocarditis using 99m Tc-pyrophosphate and 201 Tl for the diagnosis of coronary artery disease by stress and rest imaging in one session using 99m Tc-2-methoxyisobutylisonitrile ( 99m Tc-MIBI) and 201 Tl [1, 2] . However, these images are noisy due to the unfavorable physical properties of 201 Tl, the down-scatter of 99m Tc photons [2] , and the 5-10-fold higher activity of 99m Tc (10-20 mCi) than 201 Tl (2 mCi) in clinical use. Dual-isotope studies with 99m Tc and 123 I may be useful for various organs, including the brain [3, 4] and myocardium [5] . Sequential injection of 123 I-Nisopropyl-p-iodoamphetamin ( 123 I-IMP) and 99m Tchexamethylpropyleneamine oxime ( 99m Tc-HMPAO) in subjects under control and Diamox-stressed conditions was developed to evaluate changes in regional cerebral blood flow by SPECT imaging [3] . Although 99m Tc and 123 I have excellent physical properties for SPECT imaging, the similarity of the photo-peak energies (140 keV vs. 159 keV) between these two isotopes may interfere with image information, particularly if the energy windows of each isotope cannot be set properly [4] . Therefore, it is important to define the optimal energy windows and to measure the cross interference between these two isotopes in each laboratory before performing simultaneous 99m Tc/ 123 I dual-isotope SPECT.
The feasibility of simultaneous dual radionuclide brain imaging with 99m Tc and 123 I using photo-peak image subtraction techniques or offset photo-peak image acquisition have been evaluated with a phantom brain simulation for regional cerebral blood flow [6] . However, the images are affected by scatter, cross-talk, attenuation, distance-dependent collimator responses, and partial-volume effect [7] . Therefore, the parameters used for simultaneous 99m Tc/ 123 I assessment of regional cerebral cortex blood flow may not be adequate for radiotracers that specifically concentrate on the striatal region, or those that become concentrated in the center of the cerebral hemispheres.
With the development of 99m Tc-TRODAT-1 as a 99m Tc-labeled radiotracer for presynaptic dopamine transporter imaging [8] and the availability of 123 I-IBZM as a 123 I-labeled radiotracer for dopamine D2/D3 receptor imaging [9] , the simultaneous dualisotope SPECT imaging technique has had a considerable impact on imaging the brain dopaminergic system in patients with movement disorders [10] .
In Taiwan, both 99m Tc-TRODAT-1 and 123 I-IBZM are available from the Institute of Nuclear Energy Research of the Atomic Energy Council. The dualisotope SPECT imaging technique offers a great opportunity for researchers to aid differential diagnosis, to evaluate the severity, and to monitor disease progression in patients with movement disorders. The purpose of this study was to evaluate the energy cross-interference between 99m Tc and 123 I with an offpeak energy window setting for 123 I in a simultaneous 99m Tc-TRODAT-1 and 123 I-IBZM dual-isotope SPECT acquisition and to correlate the image results from a phantom brain striatal preparation at different striatalto-background ratios.
MATERIALS AND METHODS

Phantom preparation
A commercially available, dedicated, five-compartment striatal phantom (RSD Inc., Long Beach, CA, USA) was used for all studies. This tissue-equivalent anthropomorphic brain phantom consists of a left caudate nucleus (LC), right caudate nucleus (RC), left putamen (LP), right putamen (RP) and the remainder of the brain as one compartment. Each compartment was filled with radioactive solutions ( 99m Tc, 123 I or both) to simulate the accumulation of 99m Tc-TRODAT-1 and 123 I-IBZM in the brain.
For all experiments, two different radioactive concentration solutions were prepared, one for the striatal chambers (LC, RC, LP and RP) as a target organ and the other for the rest of the brain as a background chamber. The solutions were diluted according to the different striatum-to-background ratios (3:1, 6:1 or 9:1) for the individual experiments. In separate experiments, the striatal chambers and the background chamber were filled with solutions containing 99m Tc only, 123 I only, or both radioisotopes. The actual filling activities and the resulting experimental ratios are summarized in Table 1 .
Image acquisition and processing
A triple-head gamma camera (Siemens MultiSPECT3; Siemens AG, Munich, Germany) equipped with ultrahigh resolution fan-beam collimators was used for SPECT image acquisition. The acquisition parameters comprised a rotational radius of 13.9 cm, 120 projection angles over 360° with 30 seconds/projection and a 128 × 128 matrix size. The energy window was centered at 140 keV with a 15% window for 99m Tc and a 10% asymmetric window with a lower bound at 159 keV for 123 I. This window setting combination represents a compromise between cross-interference and count statistics. The projection images were reconstructed by filtered back-projection with a Butterworth filter and Chang's first order for uniform attenuation correction.
Data analysis
Regions of interest in the caudate nucleus, the putamen and the occipital areas were drawn based on a magnetic resonance image. The relative activity ratios were calculated by dividing the mean counts per pixel in the four chambers (target) with the mean counts per pixel in the occipital area (background).
To calculate the crossed interference, for example the 123 Tc count/pixel/μCi in single-isotope study
The reproducibility of the counting activity and the different target/background ratios for each isotope were determined. The correlation for striatal-tobackground ratios between the single isotopes and simultaneous dual-isotope SPECT was calculated by least square regression analyses.
RESULTS
Based on the average count (count/pixel/μCi), the down-scattering of 123 22.0 ± 12.4% of the 123 I counts measured in a 10% asymmetric 123 I window ( Table 2 ). Using the asymmetric 123 I window, only 0.4 ± 1.0% of the counts in that window were from 99m Tc. A net interference of 7.1 ± 4.0% of the counts in a 15% centered 99m Tc window was from 123 I and a net interference of 1.6 ± 3.3% of the counts in a 10% asymmetric 123 I window was from 99m Tc. Qualitatively, the images of the single-and dualisotope studies did not differ significantly. Transverse images of the 99m Tc and 123 I simultaneous dual-isotope striatal phantom SPECT were prepared and possible artifacts due to septal penetration of the high energetic 123 I photons were not observed (Figure) .
There was a good correlation (R 2 = 0.99) for the striatum-to-background ratios obtained from SPECT results between the single-and dual-isotope images of both 99m Tc and 123 I isotopes (Table 3 ).
DISCUSSION
With the development of 99m Tc-TRODAT-1 as 99m Tclabeled DAT ligand [8] and the availability of 123 I-IBZM as 123 I-labeled dopamine D2/D3 receptor ligand [9] , simultaneous dual-isotope SPECT imaging has considerable impact on imaging the brain dopaminergic system in patients with movement disorders. With successful simultaneous 99m Tc-TRODAT-1 and 123 I-IBZM dual-isotope SPECT in baboon [10] and monkey [11] studies, this imaging technique has enormous potential in neurology and psychiatry to aid in not only differential diagnosis but also in monitoring treatment response [12] . In Taiwan, both 99m Tc-TRO-DAT-1 and 123 I-IBZM are available from the Institute of Nuclear Energy Research of the Atomic Energy Council. It is a great opportunity for researchers in Taiwan to use 99m Tc-TRODAT-1 and 123 I-IBZM dualisotope SPECT in patients with neurological and psychiatric disorders. Simultaneous 99m Tc-TRODAT-1 and 123 I-IBZM imaging is a powerful technique to image the dopamine system under the same physiological status with a very accurate spatial registration. This technique also saves time on data acquisition; patients can complete two studies in one visit, which is important for movement disorder patients. Therefore, it is of great clinical interest to be able to simultaneously image two functionally separate binding sites within the same organ.
Simultaneous dual-isotope imaging is particularly desirable if two radiopharmaceuticals labeled with different isotopes bind to functionally different sites or display functions in different physiologic stages in the same anatomical area. Dual-isotope acquisitions produce images that are in highly accurate spatial registration with each other. Therefore, analytical errors due to different positions of the subject in two different scans can be minimized. The images shown in the Figure indicate the identical transverse image slices of 99m Tc-TRODAT-1 and 123 I-IBZM without software coregistration. Furthermore, physiologic differences in ligand binding due changes in blood flow and different receptor status, with or without medication, can be eliminated. These factors may affect the results of studies performed on different days. Despite the above-mentioned advantages, dualisotope imaging approaches could potentially produce degraded and interfered images due to the excess labeling of the second radioisotope [3, 4] . Close attention to several important factors is required to produce accurate images that reflect the distribution of each isotope. The factors include optimal energy window settings, energy-dependent uniformity, and the degree of interference (cross-talk) in separate and simultaneous acquisition of dual-isotope imaging [3, 4] . In this study, we demonstrated an appropriate energy window setting, which resulted in a good correlation for the striatal-to-background ratios between single-and dual-isotope imaging in both 99m Tc-TRODAT-1 and 123 I-IBZM images. In this study, we focused on striatal uptake of 99m Tc-TRODAT-1 and 123 I-IBZM using a striatal phantom with attenuating media and background activity in the brain shell to represent the clinical situation of the dopaminergic system as closely as possible. A SPECT equipped with ultra-high resolution fan-beam collimators was used for all of our experiments, instead of conventional parallel hole-collimators to increase the resolution for clinical use. With a 15% asymmetric energy window for 99m Tc, the down-interference by 123 I was high (22%), but the net interference was only 7.1% because the 99m Tc activity (25 mCi) was five times higher than that of 123 I (5 mCi) in current clinical use.
However, it is important to note that our results are appropriate only for very specific equipment, i.e. the type of collimators used, the specific acquisition protocols and the reconstruction procedures that we currently use [13] . For example, a lower-resolution collimator or a different reconstruction filter could possibly alter the magnitude of the effects observed. Therefore, every nuclear medicine department that intends to use 99m Tc-TRODAT-1 and 123 I-IBZM dualisotope SPECT for human striatal dopaminergic imaging must perform a similar phantom study with specific collimators and reconstruction parameters to evaluate the appropriateness of the imaging protocol for clinical use. Here, we demonstrated the principle and the results of our experiment as a paradigm to evaluate the parameters with a specific SPECT instrument and imaging reconstruction methods.
CONCLUSION
The data presented in this report are derived from dedicated striatal phantom studies and suggest that simultaneous dual-isotope SPECT imaging of the striatum using 99m Tc-labeled and 123 I-labeled radiopharmaceuticals is feasible. Comparable image quality and striatal-to-background ratios were observed for the single-and dual-isotope experiments. The success of this simultaneous dual-isotope SPECT technique reported here warrants further studies using 99m Tc-TRODAT-1/ 123 I-IBZM simultaneous dualisotope SPECT for both dopamine transporter/ D2 receptor imaging in the differential diagnosis 
